R. E. Buck
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 9
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Antibiotic Use and Resistance 2
- Clinical Biochemistry top 10%
-
- Antimicrobial Resistance in Staphylococcus 6
-
- Cancer therapeutics and mechanisms 3
-
- Vascular Anomalies and Treatments 1
-
- Fermentation and Sensory Analysis 1
-
- Bacteriophages and microbial interactions 1
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)The Journal of Antibiotics (3 papers)Infection (2 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
R. E. Buck
16 papers receiving 364 citations
Peers
Comparison fields: 5 of 77
- Molecular Medicine 194
- Pharmacology 318
- Applied Microbiology and Biotechnology 30
- Clinical Biochemistry 45
- Drug Discovery 1
Countries citing papers authored by R. E. Buck
This map shows the geographic impact of R. E. Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Buck more than expected).
Fields of papers citing papers by R. E. Buck
This network shows the impact of papers produced by R. E. Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Buck. The network helps show where R. E. Buck may publish in the future.
Co-authorship network
The 15 scholars most cited alongside R. E. Buck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 2 | |
| 2 | 1987 | 55 | |
| 3 | 1985 | 141 | |
| 4 | 1985 | 3 | |
| 5 | 1984 | 26 | |
| 6 | 1980 | 7 | |
| 7 | 1980 | 4 | |
| 8 | 1979 | 14 | |
| 9 | 1979 | 8 | |
| 10 | 1977 | 92 | |
| 11 | 1976 | 43 | |
| 12 | 1975 | 26 | |
| 13 | 1972 | 3 | |
| 14 | 1964 | 20 | |
| 15 | A comparison of the in vitro susceptibility of HeLa and protozoan cells to antitumor antibiotics. | 1962 | 6 |
| 16 | Massive hematemesis from a cirsoid aneurysm in a forty-year-old man. Report of a fatal case. | 1951 | 2 |
About R. E. Buck
R. E. Buck is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Infectious Diseases and Small Animals, having authored 16 papers that have together received 452 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Cancer therapeutics and mechanisms (3 papers), Antibiotic Use and Resistance (2 papers), Vascular Anomalies and Treatments (1 paper), Fermentation and Sensory Analysis (1 paper) and Bacteriophages and microbial interactions (1 paper). The work is most often cited by research in Molecular Medicine (194 citations), Pharmacology (318 citations), Applied Microbiology and Biotechnology (30 citations), Clinical Biochemistry (45 citations) and Drug Discovery (1 citation). R. E. Buck has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include K. E. Price, F. Leitner, M Misiek, T. A. Pursiano, R E Kessler, J V Desiderio, J. Lein, Koko Sugawara, Takeo Miyaki and Minoru Hanada. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Infection, PRIMUS and Applied Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.